Medsafe has opened a consultation on proposals to reduce barriers to accessing clozapine, a medicine used to treat treatment-resistant schizophrenia.

A formal regulatory inspection of Canterbury-based mental health services has set out a series of recommended changes for Health New Zealand and is continuing checks over the next 12 months.

Health providers and products we regulate, and laws we administer.

In addition to the briefings published below, we also publish additional information alongside Cabinet material, including briefings to Ministers. These can be found at Information releases.Some parts ...

Residential disability services must notify the Ministry of Health before undertaking any of the following changes: changing patient or client capacity transferring existing clinical services ...

This framework contains information for health professionals and the public on the standards they should expect for evidence-based assessment, diagnosis, and treatment for ADHD in New Zealand.

We proactively release advice that the Associate Minister of Health has received from the Ministry of Health as part of our commitment to openness and transparency.

This Cabinet material sets out decisions on proposals to update the Government’s strategic direction for primary care and changes to funding to improve New Zealanders’ timely access to quality primary ...

The Ministry of Health has issued a public warning about the Suntree - Vanilla Cream (30ml) vaping product as it contains too much of a chemical associated with a lung injury called ‘popcorn lung’.

This privacy statement applies to the Ministry of Health Jobs website, which is owned and administered by the Ministry of Health New Zealand.

An audit report is created when a rest home undergoes an audit for certification under the Health and Disability Services (Safety) Act 2001. These audits assess whether the rest home meets the ...